PROKARYOTES

crossm Draft Genome Sequence of Citrobacter freundii Strain A47, Resistant to the Mycotoxin Deoxynivalenol Rafiq Ahad,a,b* Ting Zhou,a Dion Lepp,a K. P. Paulsb Guelph Food Research Center, Agriculture Agri-Food Canada, Guelph, Ontario, Canadaa; Department of Plant Agriculture, University of Guelph, Guelph, Ontario, Canadab

ABSTRACT Here, we present the draft genome sequence of Citrobacter freundii strain A47 with a length of 4,878,242 bp, which contains 4,357 putative protein coding genes, including 270 unique genes. This work is expected to assist in obtaining novel gene(s) that code for deoxynivalenol (DON) de-epoxidation enzyme(s).

A

grifood commodities are often contaminated with hazardous mycotoxins such as deoxynivalenol (DON), produced by toxigenic Fusarium species (1–3). A potential environmentally friendly and effective method for addressing the problem may be the removal of the mycotoxin via enzymatic de-epoxidation (4, 5). In previous work toward this goal (6), a Gram-negative bacterial strain, Citrobacter freundii A47, was isolated from an enriched microbial culture that showed de-epoxidation activity at high concentrations of DON (500 ␮g/mL). The high level of DON de-epoxidation activity observed for C. freundii A47 led us to sequence its genome as it may contain DON de-epoxidation genes and enzymes. The genome of C. freundii A47 was sequenced using an Illumina HiSeq 2000 platform at the Beijing Genomics Institute (BGI), Hong Kong. A 500 bp library was produced and sequenced with 90-bp paired-end reads. The raw data was filtered by removing ⬎10% reads that include N’s or low complexity reads, low quality (ⱕQ20) bases, and adapter contamination, generating 126,619,724 filtered reads. Quality assurance was done by analysis of G⫹C content, depth correlation, and K-mer values. The cleaned short reads (180 bp) were assembled using SOAPdenovo v2. The assembly generated 439 contigs (N50 value: 29,222 bp) and 79 scaffolds (N50 value: 325,726 bp). The assembly represents a 107⫻ coverage of total scaffolds with a total sequence length of 4,878,242 bp. The genome has an overall G⫹C content of 52%. The genome consists of an 88% coding sequence that represents 4,357 protein coding genes. Since the DON de-epoxidation reaction is a reduction, the genome of C. freundii A47 was searched for reductase genes that are not present in closely related Citrobacter species that do not show de-epoxidation activity (7, 8). The analysis was done by all-versus-all reciprocal BLAST comparisons of coding sequences of strain A47 and genomes of five Citrobacter species in NCBI GenBank that are not expected to have DON de-epoxidation genes. The analysis was based on at least 30% amino acid identity and ⬎70% coverage of the total length of the gene, using the OrthoMCL program (9). The comparative genome analysis resulted in the identification of 270 unique protein coding or hypothetical genes, including eight reductases as potential DON deepoxidation genes in C. freundii A47. The accession numbers of the protein coding genes for reductases in the NCBI database are OCF82123.1, OCF82124.1, OCF80241.1, OCF83243.1, OCF83247.1, OCF83248.1, OCF81253.1, and OCF82809.1. Functional analyses of the proteins encoded by these unique reductase genes may lead to the identification of genes encoding DON de-epoxidizing enzymes. Subsequent biotechVolume 5 Issue 11 e00019-17

Received 6 January 2017 Accepted 12 January 2017 Published 16 March 2017 Citation Ahad R, Zhou T, Lepp D, Pauls KP. 2017. Draft genome sequence of Citrobacter freundii strain A47, resistant to the mycotoxin deoxynivalenol. Genome Announc 5:e00019-17. https://doi.org/10.1128/genomeA.00019-17. © Crown copyright 2017. This is an openaccess article distributed under the terms of the Creative Commons Attribution 4.0 International license. Address correspondence to Rafiq Ahad, [email protected] * Present address: Rafiq Aahd, Biodiversity Institute of Ontario, University of Guelph, Ontario, Canada.

genomea.asm.org 1

Ahad et al.

nological utilization of these genes could contribute to a safer supply of foods and feeds that are devoid of DON. Accession number(s). This whole-genome shotgun project has been deposited in NCBI GenBank under the accession no. LNFS00000000. The version described in this paper is the first version, LNFS00000000.1. ACKNOWLEDGMENTS We thankfully acknowledge the Natural Sciences and Engineering Research Council of Canada (NSERC) for awarding a scholarship to R.A. for the Ph.D. program. This work was financed by the AAFC/BARD (Canada-Israel) Binational Program granted to T.Z. and NSERC BARD granted to K.P.P.

REFERENCES 1. Pestka JJ, Smolinski AT. 2005. Deoxynivalenol: toxicology and potential effects on humans. J Toxicol Environ Health 8:39 – 69. https://doi.org/ 10.1080/10937400590889458. 2. Bianchini A, Horsley R, Jack MM, Kobielush B, Ryu D, Tittlemier S, Wilson WW, Abbas HK, Abel S, Harrison G, Miller JD, Shier WT, Weaver G. 2015. DON occurrence in grains: a North American perspective. Cereal Foods World 60:32–56. https://doi.org/10.1094/CFW-60-1-0032. 3. Sherif SO, Salama EE, Abdel-Wahhab MA. 2009. Mycotoxins and child health: the need for health risk assessment. Int J Hyg Environ Health 212:347–368. https://doi.org/10.1016/j.ijheh.2008.08.002. 4. Swanson SP, Helaszek C, Buck WB, Rood HD, Haschek WM. 1988. The role of intestinal microflora in the metabolism of trichothecene mycotoxins. Food Chem Toxicol 26:823– 829. https://doi.org/10.1016/0278-6915(88) 90021-X.

Volume 5 Issue 11 e00019-17

5. Sundstøl Eriksen GS, Pettersson H, Lundh T. 2004. Comparative cytotoxicity of deoxynivalenol, nivalenol, their acetylated derivatives and deepoxy metabolites. Food Chem Toxicol 42:619 – 624. https://doi.org/ 10.1016/j.fct.2003.11.006. 6. Ahad R, Zhou T, Lepp D, Pauls P. 2017. Microbial detoxification of eleven trichothecene mycotoxins. BMC Biotechnol, in press. 7. Yoshizawa T, Takeda H, Ohi T. 1983. Structure of a novel metabolite from deoxynivalenol, a trichothecene mycotoxin, in animals. Agric Biol Chem 47:2133–2135. 8. He PI, Young LG, Forsberg C. 1992. Microbial transformation of deoxynivalenol (vomitoxin). Appl Environ Microbiol 58:3857–3863. 9. Li L, Stoeckert CJ, Roos DS. 2003. OrthoMCL: identification of ortholog groups for eukaryotic genomes. Genome Res 13:2178 –2189. https:// doi.org/10.1101/gr.1224503.

genomea.asm.org 2

Draft Genome Sequence of Citrobacter freundii Strain A47, Resistant to the Mycotoxin Deoxynivalenol.

Here, we present the draft genome sequence of Citrobacter freundii strain A47 with a length of 4,878,242 bp, which contains 4,357 putative protein cod...
120KB Sizes 0 Downloads 4 Views

Recommend Documents


Draft genome sequence of Citrobacter freundii strain ST2, a γ-proteobacterium that produces N-acylhomoserine lactones.
Citrobacter freundii strain ST2, isolated from the algae bloom sample, possesses an N-acylhomoserine lactone (AHL) production activity that secretes short-chain AHL molecules. In this study, we sequenced the complete genome of C. freundii strain ST2

Finished Genome Sequence of the Highly Multidrug-Resistant Human Urine Isolate Citrobacter freundii Strain SL151.
Citrobacter freundii is a Gram-negative opportunistic pathogen that is increasingly being recognized as a causative agent of hospital-acquired urinary tract infections and an important reservoir of antimicrobial resistance determinants. In this repor

Complete Genome Sequence of Citrobacter freundii Myophage Miller.
Citrobacter freundii is a Gram-negative, opportunistic pathogen that can be fatal to newborns or immunocompromised patients. Bacteriophages against this bacterium can be useful for therapeutic purposes. Here, we describe the complete genome and the k

Complete Genome Sequence of Citrobacter freundii Myophage Moogle.
Citrobacter freundii is an opportunistic pathogen that has been linked to nosocomial infections, such as brain abscesses and pneumonia. Further study on phages infecting C. freundii may provide therapeutics for these infections. Here, we announce the

Complete Genome Sequence of Multidrug-Resistant Citrobacter freundii Strain P10159, Isolated from Urine Samples from a Patient with Esophageal Carcinoma.
Citrobacter freundii is an opportunistic pathogen that can cause diarrhea, septicemia, meningitis, and urinary tract infections. We report here the complete genome sequence of C. freundii strain P10159, isolated from urine samples from a patient in C

Complete Genome Sequence of Citrobacter freundii Myophage Mordin.
Citrobacter freundii is a Gram-negative opportunistic pathogen that is associated with urinary tract infections. Bacteriophages infecting C. freundii can be used as an effective treatment to fight these infections. Here, we announce the complete geno

Complete Genome Sequence of Citrobacter freundii Myophage Moon.
Citrobacter freundii and other Gram-negative opportunistic pathogens necessitate concern from the public health sector. Bacteriophages that kill such pathogens may be useful in the control and containment of these infections. Here, we describe the ge

Complete Genome Sequence of Citrobacter freundii Myophage Mijalis.
Citrobacter freundii is responsible for various opportunistic nosocomial infections. Phage therapies against C. freundii may prove useful in human medicine for treatment of infections caused by the ubiquitous bacteria. Here, we announce the complete

Complete Genome of Citrobacter freundii Siphophage Stevie.
Citrobacter freundii is an opportunistic pathogen responsible for many urinary tract infections acquired in hospitals and is thus a concern for public health. C. freundii phage Stevie might prove beneficial as a treatment against these infections. Th

Complete Genome Sequence of Citrobacter freundii 705SK3, an OXA-48-Encoding Wastewater Isolate.
We present the genome sequence of Citrobacter freundii 705SK3, a wastewater isolate harboring an IncL OXA-48-encoding plasmid. Assembly of the genome resulted in a 5,242,839-bp circular chromosome (GC content, 52%) and two closed plasmids of 296,175